Skip to main content
. 2009 Apr 12;69(2):374–379. doi: 10.1136/ard.2009.107805

Figure 1.

Figure 1

Percentage of responders over baseline at various levels of reductions in pain intensity (PR) for placebo and five active drugs over 12 weeks of treatment.